Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Scisparc Ltd (SPRC)

Scisparc Ltd (SPRC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 930
  • Shares Outstanding, K 535
  • Annual Sales, $ 1,310 K
  • Annual Income, $ -6,280 K
  • EBIT $ 0 M
  • EBITDA $ -7 M
  • 60-Month Beta 1.67
  • Price/Sales 0.72
  • Price/Cash Flow N/A
  • Price/Book N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.5500 +12.26%
on 12/05/25
3.3199 -47.59%
on 11/26/25
-1.2700 (-42.19%)
since 11/05/25
3-Month
1.5500 +12.26%
on 12/05/25
8.9000 -80.45%
on 09/25/25
-0.4900 (-21.97%)
since 09/05/25
52-Week
1.5500 +12.26%
on 12/05/25
37.5900 -95.37%
on 01/06/25
-2.9346 (-62.78%)
since 12/05/24

Most Recent Stories

More News
SciSparc Ltd. Finalizes Agreement with Miza III Ventures for Asset Transfer

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. SciSparc...

SPRC : 1.7400 (-1.69%)
SciSparc Ltd. Terminates Merger Agreement with AutoMax Motors

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. SciSparc...

SPRC : 1.7400 (-1.69%)
Small Caps Shine Following Fed’s First Rate Cut in 9 Months

The Federal Reserve delivered its first rate cut in nine months, and small-cap stocks wasted no time celebrating. While the S&P 500 (SPX) dipped modestly and the Russell 3000 Index (RUA) closed near even,...

IPM : 1.8700 (+0.54%)
MNPR : 80.38 (+1.15%)
SPRC : 1.7400 (-1.69%)
BGM : 7.00 (-4.89%)
BLDP : 2.82 (+0.71%)
IWV : 389.40 (+0.13%)
SQFT : 4.19 (+5.81%)
APLM : 16.27 (+10.34%)
GV : 1.4200 (-2.07%)
TVRD : 4.18 (unch)
THH : 18.50 (+0.82%)
WFC : 89.83 (-0.42%)
SciSparc Ltd. Announces Amendment to LOI for Spin-Off of Pharmaceutical Assets Valued at Approximately $11.6 Million

SciSparc and Miza Ventures amend LOI for asset transfer, valuing SciSparc's assets at $11.6 million.Quiver AI SummarySciSparc Ltd., a clinical-stage pharmaceutical company, announced an amendment to its...

SPRC : 1.7400 (-1.69%)
SciSparc Slides Following AutoMax Deal

SciSparc Ltd. (NASDAQ: SPRC) shares lost ground Wednesday, after it announced that it had entered into ...

SPRC : 1.7400 (-1.69%)
SciSparc Announces Israeli Ministry of Health Approval to Conduct its Clinical Trial in Autism Spectrum Disorder

The trial's objectives are to evaluate the safety, tolerability and efficacy of SciSparc's SCI-210 in children and adolescents with ASD TEL AVIV,...

SPRC : 1.7400 (-1.69%)
SciSparc Signs Clinical Trial Agreement with Yale University to Conduct its Phase IIb Trial in Tourette Syndrome

The addition of a U.S. site will allow SciSparc to accelerate trial recruitment and further development of novel treatments for patients in need TEL...

SPRC : 1.7400 (-1.69%)
SciSparc Announces Expanding its Clinical Operations to Include a U.S. Site Towards its Phase IIb Trial with its Proprietary SCI-110 for the Treatment of Tourette Syndrome

TEL AVIV, Israel, July 08, 2022 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical...

SPRC : 1.7400 (-1.69%)
SciSparc's JV MitoCareX Bio Launches its Advanced New Laboratory Facility

The new facility will serve the JV’s development of potential cancer drugs TEL AVIV, Israel, July 07, 2022 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq:...

SPRC : 1.7400 (-1.69%)
Traders News Source Interviews Oz Adler Chief Executive Officer at SciSparc Ltd.

NEW YORK, NY / ACCESSWIRE / July 7, 2022 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid cap publicly traded companies recently issued a...

SPRC : 1.7400 (-1.69%)

Business Summary

SciSparc Ltd. is a specialty clinical-stage pharmaceutical company. It focuses on the development of therapies to treat disorders of the central nervous system. The company's product pipeline includes SCI-110, SCI-160 and SCI-210. SciSparc Ltd. is based in TEL AVIV, Israel.

See More

Key Turning Points

3rd Resistance Point 2.3933
2nd Resistance Point 2.1867
1st Resistance Point 1.9633
Last Price 1.7400
1st Support Level 1.5333
2nd Support Level 1.3267
3rd Support Level 1.1033

See More

52-Week High 37.5900
Fibonacci 61.8% 23.8227
Fibonacci 50% 19.5700
Fibonacci 38.2% 15.3173
Last Price 1.7400
52-Week Low 1.5500

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar